CXL Improved Morphological, Functional Parameters in Select Age Groups
Corneal collagen cross-linking (CXL) stabilized the
progression of ectatic disease 4 years postoperatively
in all age groups and improved the functional and
morphological parameters in select groups, with the
best results in patients between 18 and 39 years of age,
according to a study in emOphthalmology/em.sup1/sup
...